Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Hydrocortisone recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Hydrocortisone (70 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Hydrocortisone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Hydrocortisone recalls on record

none so far in 2026; 70 on record, newest first
Class III · Low risk

Hydrocortisone and acetic acid otic solution

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).

Terminated Impurity / degradation Actavis Inc NDC 45963-412-61 D-1472-2016
Class III · Low risk

Acetasol HC

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).

Terminated Impurity / degradation Actavis Inc NDC 0472-0882-82 D-1471-2016
Class II · Moderate risk

GRx HiCort 25

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-015-12 D-0392-2016
Class II · Moderate risk

Solu-Cortef

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0640-2016
Class III · Low risk

Hydrocortisone and Acetic Acid Otic Solution

Defective Container: Product missing safety seal around the neck of the bottle. The product label indicates, "Tamper Evident: Do not use if printed seal around cap is broken or missing." Because the product is missing the approved component and is not consistent with the labeling, the lot is being recalled.

Terminated Packaging defect Akorn, Inc. NDC 50383-901-10 D-0295-2016
Class II · Moderate risk

Hydrocortisone 1.6 mg/0.5 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1062-2015
Class II · Moderate risk

Hydrocortisone Sodium Succinate active pharmaceutical ingredient…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-716-2015
Class II · Moderate risk

Hydrocortisone Micronized active pharmaceutical ingredient…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-715-2015
Class II · Moderate risk

Hydrocortisone base active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-714-2015
Class II · Moderate risk

Hydrocortisone active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-713-2015
Class III · Low risk

Hydrocortisone Butyrate Cream 0.1%

Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point

Terminated Wrong potency / content Valeant Pharmaceuticals International NDC 43478-270-15 D-0025-2015
Class II · Moderate risk

Hydrocortisone

Labeling: Label Mixup: HYDROCORTISONE, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: carBAMazepine ER, Tablet, 200 mg, NDC 51672412401, Pedigree: AD60272_7, EXP: 5/22/2014; guanFACINE HCl, Tablet, 1 mg, NDC 00591044401, Pedigree: W002728, EXP: 4/30/2014; glyBURIDE, Tablet, 1.25 mg, NDC 00093834201, Pedigree: AD21790_10, EXP: 2/28/2014; ACARBOSE, Tablet, 25 mg

Terminated Labeling / mix-up Aidapak Services, LLC D-984-2014
Class II · Moderate risk

HYDROCORTISONE Tablet

Labeling: Label Mixup; HYDROCORTISONE Tablet, 5 mg may be potentially mislabeled as ORPHENADRINE CITRATE ER, Tablet, 100 mg, NDC 43386048024, Pedigree: W002962, EXP: 6/11/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: W003045, EXP: 6/12/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-695-2014